Cancer therapies that target VEGF receptor appear safe and effective for patients with pancreatic and non-pancreatic neuroendocrine tumors, meta-analysis of phase 2/3 clinical trials demonstrates.

Nobel Prize-winning geneticist and cell biologist Sir Paul Nurse, PhD, will be at Vanderbilt Thursday, Feb. 9, to deliver the year's first Discovery Lecture.

Similar rates of bilateral mastectomy in women with inherited mutations in high- and moderate-penetrance genes raises concerns about possible overtreatment of some patients, Vanderbilt researchers report.

He gave up baseball to become a surgeon. That decision may have saved his life.

Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened.

Immature nerves and neural precursor cells increase in density as a type of premalignant tumor in the pancreas progresses to invasive disease, suggesting that blocking these cells may arrest malignant progression.

The number of sarcoma research studies that use the two largest U.S. cancer registries is increasing, but over one-third of studies that asked the same research question reported conflicting findings.